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The  successful  use of the fluoropyrimidines to gain information  about the 
synthesis of viral DNA (1-3) led us to a study of their effect on the replication 
of vacuolating  virus  (SV40).  This  agent  belongs  to  the  papovavirus  group  1 
(4)  which is characterized  by 40 to 50 m/~ icosahedral particles possessing  a 
shell of 42 capsomeres and a core of DNA (5, 6). As the time sequence of virus 
production in the one-step growth cycle had already been determined for SV40 
(7),  experiments  could be readily  designed  with  5-fluorouracil  (FU)  and  5- 
fluorodeoxyuridine (FUDR) to determine whether the synthesis of infectious 
virus might  be suppressed  while  the  formation  of viral  proteins  continued. 
Reissig  and  Kaplan  (1)  had  shown  that  with  another  icosahedral  DNA- 
containing virus (swine herpes virus or pseudorabies) grown in the presence of 
FU, viral protein was assembled into empty particles having the size and shape 
of herpes virus but without DNA cores. In view of the well known tumorigenic 
activity  of  the  papovaviruses,  and  the  recent  finding  that  SV40-induced 
tumors and transformed cells may contain complement-fixing  viral antigen in 
the  absence  of  infectious  virus  (8),  information  on  the  formation  of  viral 
antigens in cells which fail to make infectious virus is highly desirable. 
Materials and Methods 
Virus.--The same frozen stock of virus that had been used for determining the growth cycle 
of SV40 (7) was employed. Its titer was 10  ~'5 plaque-forming units (PFU) per ml. The detailed 
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AI-05382 from the National Institute of Allergy and Infectious Diseases, United States Pub- 
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1 Papovavirus was officially accepted as the name for the papiUoma-polyoma-vacuolating 
group of viruses by the International  Subcommittee on Viral Nomenclature,  International 
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properties of the virus and its development in green monkey kidney cells, as followed by acri- 
dine orange staining, fluorescent antibody staining, and electron microscopy, are described in 
the previous report  (7). Studies of the tumorigenic and cell-transforming properties of  this 
same strain of virus have also been published (9). 
Cell  Cultures.--These  were  prepared  from  African  green  monkey  ceils  (Cercopithe~us 
aethiops sabaeus) using lactaibumin hydrolysate medium (M-H for growth and M-E/or main- 
tenance) as already described (10).  No serum was present in the maintenance medium. 
Plaque Assay in Bottles.--The method developed for SV40 has been published (11),  but 
instead of a second (neutral red) overlay, a new medium was used which allowed the dye to be 
incorporated in the original agar at a final concentration of 1:60,000 (12). 
Procedure for Measuring  Virus Yields in Presence of FU and FUDR.--Cultures containing 
about 2 to 3 million cells in 1 ounce bottles were incubated 18 to 24 hours with maintenance 
medium containing the amount of drug which was to be used for the subsequent incubation 
with virus. The cultures were then drained and inoculated with 0.4 ml of fluid containing 
107.5 PFU/ml, an input multiplicity of about 10 PFU per cell. After an adsorption period of 
5 hours at 37°C,  the inoculum was decanted, and the cultures were washed five times with 
saline. Four ml of maintenance medium containing inhibitor was added to each bottle. Two 
cultures receiving each drug level were frozen for assay of adsorbed  virus. The remaining 
infected cultures were incubated at 37°C and frozen 72 hours postinoculation for assay of total 
virus yield.  Cultures to  be stained with hematoxylin and eosin or with fluorescein-labeled 
globulin as described below, were pretreated with the drug in the same way. 
As a control, the effect of 5-FU on the growth of poliovirus, previously studied in detail by 
Munyon and Salzman (13), was followed under similar conditions. Green monkey kidney cul- 
tures were incubated for 3  days in maintenance medium with 12 #g FU/ml, while control 
cultures were kept in medium without inhibitor. Cultures were drained and inoculated with 
0.1 ml of poilovirus type 1 and incubated at 37°C. After 2 hours, they were washed four times 
with Hanks' salt solution, and then 4 ml of maintenance medium, with or without inhibitor 
as indicated, was added to each bottle. Treated and untreated cultures were frozen for titra- 
tion of adsorbed virus. Others were frozen 8  hours postinoculation for assay of total virus 
yield. 
Cell Counts.--Uninoculated  cultures  of  green  monkey  kidney  cells were  held  in  main- 
tenance medium with various levels of FU or FUDR. Direct counts were made to determine 
whether the ceils multiplied or decreased in number under the experimental conditions em- 
ployed. It was found that the drug levels used in these experiments did not cause significant 
reduction in the total number of cells present during the time intervals studied, nor did un- 
treated cultures, already full sheets at the time they were used, multiply further in the ab- 
sence of serum. Thus differences in cell number did not play a role in influencing virus yields 
in these experiments. 
Hematoxylln  and Eosin  Staining.--Cells to be stained with hematoxylin and eosin were 
grown and inoculated on coverslips in Leighton tubes. They were harvested at the intervals 
indicated below, rinsed in tris buffer, and fixed for 15 minutes in Bouin's picric acid fixative. 
They were hydrated through decreasing concentrations of ethyl alcohol, stained 8 seconds in 
0.5  per  cent hematoxylin, rinsed in water,  and  counterstained 4  seconds with  1 per cent 
eosin Y. Cells were then dehydrated through increasing concentrations of ethanol, placed in 
xylol, and mounted on clean slides with permount (Fisher Scientific Company, New York). 
Fluorescent Antibody  Staining.--Two  different methods were used for the preparation of 
fluorescein-labeled globulin (14). Method 1 was the same as that used in our earlier report (7). 
The serum globulin fraction from a hyperimmunized rabbit was precipitated with cold, half- 
saturated ammonium sulfate, conjugated with fluoreseein isothiocyanate (15,  16),  and then 
passed through a  3.5 inch column of DEAE cellulose to remove unconjugated isothiocyanate. 
Aliquots  were  adsorbed  twice  with  acetone-extracted  rhesus  monkey  liver  powder  (17). ~OSEPH L. MELNICK, SARA E. STINEBAUGH~ AND :FRED RAPP  31S 
Method 2 employed as starting material a  pool of green monkey serum obtained from ani- 
mals infected by a single inoculation of the same virus stock as that used in the present experi- 
meats (18). Cold ethanol was used to precipitate the globulin by the method of Cohn el a/. (19). 
The globulin, at a final concentration of 10 mg/ml was labeled with fluorescein  isothiocyanate 
(16). The preparation was then dialyzed for 5 days against phosphate-buffered saline (pH 7.2) 
which was changed twice daily to remove uncon~ugated  fluorescein.  No color was seen in the 
saline at the last three changes. After centrifugation at 9000 ~a~ for I0 minutes, the super- 
natant fraction, containing the dissolved conjugated globulin, was dispensed in small amounts 
and stored at  -20°C. Prior to staining, an aliquot of conjugated globulin was tlmwed, ad- 
sorbed  I  hour by shaking with 100 mg/ml acetone-extracted mouse liver powder (17),  and 
centrifuged at 12,000 ~  for 45 minutes. The process was repeated with half the amount of 
liver powder, and the superuatant fraction was stored at 4°C for use within I week. 
Cells to be stained with the labeled globulin were grown on coverslips in Leighton tubes. 
When  harvested,  they were rinsed with tris buffer,  air-dried,  and  fixed  in acetone for  10 
minutes. They were stored at 4°C before staining. Coverslips to be stained with fluorescein- 
labeled globulin were removed from the refrigerator, warmed and air-dried, and reacted with 
a  drop of the conjugated globulin  (1:2)  for 30 minutes at room temperature.  They  were 
washed three times in tris buffer and left in the third wash for I0 minutes. They were blotted 
and mounted in elvanol (20) on clean slides.  These preparations were examined with a Zeiss 
fluorescence microscope with a  darkfield condenser using an 0stare  HBO-200 mercury arc 
vapor lamp for illumination. 
Electron Microscopic Examination of  Ultrathin Sections.--Drained monolayers  of  green 
monkey kidney cells in 16-otmce bottles containing about I0 million cells were inoculated with 
2 ml of SV40 containing 10  ~.5 PFU/ml. After 4 hours, the inoculum was decanted, and 20 ml 
of maintenance medium was added. Cultures to be used for the growth of virus in the pres- 
ence of FU were pretreated  18 to 24 hours with maintenance medium containing 12/zg/ml of 
the drug. The same drug-containing medium was added for incubation following the 4 hour 
adsorption period. After 3 days of incubation at 37°C, the cells were chilled in the bottles and 
fixed for 10 minutes with 1 per cent buffered OsO4 at pH 7.8. 
Cells were scraped from the bottles with a  rubber policeman and dehydrated  by passing 
through 35, 50, 70, and 95 per cent ethanol for 3 minutes each, and then left in 100 per cent 
ethanol for 5 minutes. They were then treated  (a) with 0.1 per cent phosphotungstic acid in 
100 per cent ethanol for 10 minutes,  (b) with two changes of propyleae oxide for 10 minutes 
each, and (c) with a 1:1 mixture of propylene oxide and CIBA 502 araldite resin for 90 to 120 
minutes.  When necessary, the cells were sedimented by low speed centrifugation (800  ~xr) 
between changes of fluid. 
Pellets formed by low speed centrifugation of the cells were then embedded in epoxy resin 
according to Luft's procedure  (21).  Ultrathin sections were mounted on copper grids,  and 
examined in the electron microscope. 
RESULTS 
Effect  of  5-Fluouracil  and  Its  Deoxyriboside  on  Production  of  Infectious 
Virus.--From  previous  studies  (7,  22),  the  one-step  growth  curve  for  SV40 
in green monkey cells was known  to be relatively long. With the present  stock 
of virus  at  input multiplicities of 3  to  10  PFU/cell, a  20 hour  lag period  was 
observed between the initiation of infection and the appearance of intracellular 
virus  (Text-fig.  1).  New  extracellular  virus  was  detected  several  hours  later; 
it  increased  gradually  and  remained  at  a  lower level than  the  cell-associated 
virus until 48 hours postinoculation.  At 72 hours, the titer of extracellular virus 316  SIMIAN  PAPOVAVIRIIS  SV40 
reached a plateau at a level much higher than that of the intracellular virus. 
Microscopic examination of the cultures was  carried out periodically. At 50 
hours postinoculation, some abnormal rounding of ceils was evident but there 
was no evidence of cytoplasmic vacuolation. Vacuolation and nuclear enlarge- 
ment were observed at 66 hours in 10 to 20 per cent of the cells, and at 82 hours 
in approximately 25 per cent of the ceils. 
As shown in Table I, both FU and FUDR had a marked inhibitory effect on 
the production of SV40 by infected cells.  Assays of infected cultures frozen 
immediately after adsorption and washing indicated that cells pretreated with 
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TExT-FIG, 1. Development  of intracellular and extraceUular  virus in cercopithecus  monkey 
kidney cultures inoculated with SV40. 
all drug levels contained amounts of residual virus similar to those in the non- 
treated cells.  Thus the drug did not inhibit virus adsorption to cells,  nor was 
the drug carried over into the assay system in amounts sufficient to suppress 
plaque formation. 
Production of Viral Antigen.--By the direct fluorescent antibody technique, 
we found that FU levels that suppressed virus multiplicatiort (12 to 25 gg/ml) 
allowed the  synthesis of large amounts  of viral antigen.  In all experiments, 
infected cells were harvested for fluorescent antibody studies 40 to 48 hours 
postinoculafion; at this time in the drug-free infected cells virus antigens could 
be specifically localized in  the nucleus  (7).  As  indicated in Table II,  which 
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FU also contained intranuclear antigen although fewer cells showed fluorescence 
equal in brightness to that of the untreated cells. As might be expected (23, 24), 
FUDR proved to be a  more potent inhibitor of virus antigen formation than 
FU at the same levels. 
No further experiments were performed using FUDR, but additional observa- 
tions were made to study the distribution of antigen in the FU-treated cells. 
The labeled globulin used in this and succeeding experiments was made from 
postinfection monkey serum,  which  apparently contained more specific and 
more  sensitive  antibodies  than  those  in  the  rabbit  antiserum  used  for  the 
experiments above. This made possible the detection of unmistakable differences 
in the form and distribution of virus antigens developing in untreated and FU- 
treated cells. 
TABLE I 
Inhibition of SV40 Replication  by FU and FUDR 
Yield of virus at 72 hours compared to control: 
Level of drug  FU present  FUDR present 
Exp. 1  Exp. 2 
~,g/,nl 
0 
6 
12 
25 
50 
100 
per cent 
100 
3 
2 
1 
<1 
<1 
per Cent 
100 
6 
2 
3 
1 
2 
Exp. 1  Exp. 2 
per cent  per c~t 
100  100 
1  7 
<1  <1 
<1  <1 
<1  <1 
<i  <1 
Untreated cultures and cultures exposed to 12 #g FU/ml were harvested for 
staining 40 hours after virus inoculation. In both cases,  antigen was seen in 
the nuclei of 75 to 90 per cent of the cells (Figs. 1 and 7); there was, however, 
a marked difference in the distribution of viral antigen. In the absence of FU, 
antigen  was particulate throughout the  nuclei except for the nucleoli  (Figs. 
2 to 4). The particles of antigen were coccoid and varied considerably in size; 
at  least  a  fivefold variation  was  observed  (Figs.  3  and  4).  Some cells  had 
antigen concentrated at the nuclear periphery in small masses  (Fig.  5).  Oc-. 
casional nuclei were seen with diffuse antigen (Fig. 6) or with one large mass of 
antigen virtually filling the nucleus. In the FU-treated cultures, on the other 
hand, fluorescence, while definitely present, was not quite as bright; antigen 
was seen in the nuclei in diffuse or finely granular form (Figs. 7 to 9). Nucleoli 
in  these  cultures  also  did  not  react  (Fig.  9);  in  a  few  cells,  antigen 
was  concentrated at  the periphery of the nucleus  (Fig.  10).  The fluorescent 318  SIMIAN PAPOVAVIRUS SV40 
material,  even at the nuclear membrane,  was diffuse rather  than particulate. 
Only rarely were cells seen with small particles of antigen  (Fig.  11), and none 
contained large particles or a mass filling the entire nucleus. 
Results  of another  experiment  in  which  drug levels were varied  are  given 
in Table III. Cells were again harvested for staining 40 hours after inoculation 
of virus.  Results  of an  experiment  conducted  under  the  same  conditions  to 
determine the amount of infectious virus  produced  at 72 hours postinoculation 
are included in the same table for convenience of comparison.  It can be seen 
TABLE II 
Effect of FU or FUDR on De,dopment of SV40 Virus Antigen as Detected by 
Immunofluorescence  with Labeled Rabbit Antiserum 
Level of 
drug 
ug/ml 
0 
12 
25 
50 
100 
Fluorouracil (FU)  Fluorodeoxyuridine (FUDR) 
(Control:  Particulate  intranuclear  antigen in 65-75 per cent of cells, although  a 
few cells contained a large intranuclear  antigenic mass.) 
Intranuclear  antigen  in  about  50 per 
cent  of  cells. Antigen  abnormally 
distributed in nucleus and at nuclear 
periphery. 
Intranuclear  antigen  in  30  to  50 per 
cent of cells, distributed  abnormally 
as above. 
Intranuclear antigen in 25 per cent of 
cells,  distributed  abnormally  as 
above. 
Particulate  intranuclear  antigen  seen, 
but in less than 1 per cent of cells. 
Intranuclear antigen in 1 to 10 per cent 
of cells. Particulate antigen in nucleus, 
occasionally at nuclear periphery. 
Very little  antigen  (in less than  1 per 
cent  of  cells). Antigen  scattered  in 
nucleus  or  concentrated  at  nuclear 
periphery. 
Little or no antigen. 
Little or no antigen. 
that  large  amounts  of virus  antigen  were  produced  in  the  presence  of drug 
levels which completely suppressed  the production of infectious virus. 
Cultures without virus were treated  for 60 hours with levels of FU ranging 
from 6 to 100 #g/ml and stained with the conjugated virus-immune globulin; 
no fluorescence was observed in any of the preparations  (Fig.  12). Reaction of 
infected cells with the unlabeled antiserum for 30 minutes prior to fluorescent 
antibody staining reduced the number of cells reacting from 80 per cent to less 
than 10 per cent. Cells which were stained were not as bright as those blocked 
by the unlabeled serum. Reaction with viral antibody probably failed to block 
completely the reaction with fluorescein-labeled  globulin because  of the  large 
amount of antigen present. The great reduction in the amount and intensity of 
staining  and  failure  of uninfected  cells  to react  is  sufficient  evidence  for the 
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Hematoxylin and Eosin Staining.--Infected cultures treated with 12 tzg/ml of 
FU were stained at intervals with hematoxylin and eosin for comparison with 
untreated infected cells. Uninoculated cultures with and without the drug were 
also  examined;  the  FU-treated  cells  appeared  normal  though  some  minor 
nuclear aberrations were noted (Figs.  13 and 14). 
In the inoculated  cultures,  no significant changes were seen until  40 hours 
after virus had been added, when FU-free cultures showed clumping of nuclear 
chromatin  in  almost  all  cells.  Some  nuclei  had  multiple  small  eosinophilic 
inclusions  and  others,  although  fewer  in  number,  contained  one  large 
TABLE III 
Devdopment of Infectious SV40 and of Viral Antigen in FU-Treated Cells 
#g/ral 
0 
Antigen production detected by immuno- 
Infectious  virus production  fluorescence  with labeled  postinfection 
monkey antiserum 
FU  Titer of 
culture for 
virus at 5  Titer  of 
hrs., just  culture 
after ad-  at 72 hrs. 
sorption and 
washing 
104.8  106.4 
104.s 
10~.~ 
104.8 
104.T 
12 
25 
50 
100 
CPE at 72 hrs. 
Present  in  25-50 per 
cent of cells 
Absent 
10~.0  ', 
1043;  ,, 
104.s  ,, 
Cells  con, 
raining in 
trauuclea: 
antigen 
~er c~t 
75-80 
75-80 
75-80 
50 
50 
<10 
Distribution of antigen 
in nucleus 
Particulate;  a  few  nuclei 
contained  large  masses 
of antigen 
Mainly diffuse; occasional 
nuclei  contained small 
particles of antigen 
Only  small particles  of 
antigen 
eosinophilic body. Some nuclei were enlarged to three to four times the normal 
size, and darkly staining cells were scattered over most fields. No cytoplasmic 
vacuolation was observed. At this time, changes in the drug-treated  cultures 
were  less  pronounced.  Eosinophilic  inclusions  were  both  smaller  and  fewer; 
no nuclei failed with eosinophilic masses were observed. 
By 72 hours after inoculation, fewer cells remained in the FU-free cultures, 
but their nuclei appeared the same as earlier, pyknotic with clumped chromatin 
(Figs.  15 and 16).  The cell sheets in the FU-treated cultures were intact, and 
nuclei again resembled those seen at 40 hours postinoculation  (Figs. 17 and 18). 
Occasional  nuclei,  however,  contained  small  eosinophilic  inclusion  bodies 
(Fig.  18).  While  most of the  cells remaining in  FU-free cultures  showed  ex- 320  SIMIAN  PAPOVAVIRUS  SV40 
tensive vacuolation (Figs.  15 and 16), vacuolated cells were rarely seen in the 
FU-treated cultures. In the FU-free cultures, no correlation could be observed 
between appearance of inclusions in the nucleus and of vacuoles in the cyto- 
plasm. They sometimes appeared in the same cell, but often cells showed either 
vacuolation or clumping of chromatin. 
Effect  of FU on  Polio~irus.--It  has  been  reported  (13,  25,  26)  that  the 
growth of the RNA-containing poliovirus is not inhibited by the levels of FU 
used here. As a control for the present experiments, cells were pretreated with 
12 ~g/ml of FU for 3 days, then infected with poliovirus type 1, and harvested 
after 8 hours of incubation with the drug.  Such FU-treated cultures yielded 
the same amount of virus as the untreated cultures (see Table IV). It is obvious, 
therefore, that  FU  specifically inhibits  a  DNA-containing papovavirus  at  a 
level which is without effect on the replication of an RNA-containing virus. 
Electron Microscopic Observations.--Several experiments were carried out. In 
all,  about  250  control cells and about  the  same  number of FU-treated cells 
TABLE  IV 
Development of Infectious  Poliovirus in FlY-Treated Cells 
FU  Titer of culture  for virus at 2 hrs.,  Titer of culture at 8 hrs. 
just after adsorption 
~g/ml  PFUlml  PFUIml 
0  104.4  106"e 
12  10"*  106.3 
were examined with the electron microscope3 Cells that had been exposed 3 
days earlier to SV40 in the absence of FU revealed, as already reported (7, 27, 
28), a large number of virus particles in the nuclei of almost all cells (Fig. 19). 
Nucleoli were often disrupted and in many cells the chromatin was concentrated 
just inside the nuclear membrane. Particles were sometimes seen lining cyto- 
plasmic vacuoles and sometimes formed chains enclosed by membranes. 
FU-treated cultures were also examined after 3 days of incubation. Typical 
electron micrographs are shown in Figs. 20 and 21. Very few well formed virus 
particles were seen, and  those seen were never in concentrated nests  typical 
of  the  normal  drug-free  infection.  Nucleolar  disruption  and  migration  of 
chromatin to the nuclear periphery were sometimes seen, but the changes were 
not as intense as those produced in infected cells in the absence of FU. 
DISCUSSION 
The levels of 5-fluorodeoxyuridine (FUDR)  used  in  these  studies  cause a 
marked inhibition of the production of SV40 antigen as well as infectious virus, 
2 We wish to acknowledge the able assistance of Dr. Shawky Hassan, United Arab Republic 
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similar  to  that  found in studies with other DNA viruses  (2,  3,  25,  29,  30). 
However, the incorporation  of 5-fluorouracil  (FU)  into  the culture medium: 
of SV40-infected  cells allows the synthesis of viral protein in the absence of a 
net increase in the amount of infectious virus. It is dii~cult to explain,  on the 
basis of the available evidence, the differences in the production of viral antigen 
in  the presence of FU and  FUDR. At a  concentration  of  12  to  25  ~g/rnl, 
FU permitted the synthesis of viral antigen by most cells; the same level of 
FUDR almost completely suppressed the formation of this protein.  FU has 
been found to be incorporated into the RNA of poliovirus (13) and of tobacco 
mosaic virus (31). Bussard a  a/. (32) reported that beta galactosidase produced 
by EschericMa coli in the presence of FU was antigenically normal but totally 
inactive.  They suggested that  the drug  acted on the system responsible  for 
transferring structural information from the gene, namely the RNA. A similar 
mechanism may apply in the SV40-infected  cells. If FU were incorporated into 
RNA, limited DNA synthesis might continue, but the protein produced might 
be functionally ineffective although antigenically nearly normal. If one assumes 
that synthesis of the protein of a DNA-containing virus requires at least one 
prior replication of the infecting virus DNA, FUDR might prevent the forma- 
tion of virus protein by completely suppressing synthesis of new DNA. 
The  distribution  of  virus  antigen  in  FU-treated  cells  at  40  to  48  hours 
resembles that of a much earlier stage in untreated cultures (7). In the absence 
of the drug,  cells exhibit diffuse  antigen in the nucleus 20 to 24 hours after 
infection,  at which time new intracellular  virus is just beginning  to appear, 
Then,  as virus assembly proceeds, the antigen  appears as large particulates. 
When virus synthesis is blocked by FU, the infection appears to be arrested 
at the early stage characterized by the appearance of the diffuse antigen. 
There are interesting similarities  and differences between the present experi- 
ments  and  those of Reissig and Kaplan (1) on FU-treated cells infected with 
another DNA virus exhibiting icosahedral symmetry, swine herpes virus. They 
found that the virus-induced  inclusions  in  FU-treated  cells remained  smaller 
than those in control cultures and never became Feulgen-positive. We made sim- 
ilar observations on our SV40-infected  cells treated with fluorouracil.  Definite 
indications  of nuclear  involvement were present,  but the nuclear  inclusions 
remained small and the cytoplasmic vacuoles seen normally in the last stages of 
virus replication were virtually absent in FU-treated cells. 
However, Reissig and Kaplan  (1)  found that  although  their  infected cells 
treated with FU produced as many virus particles as untreated cells, most of 
the  particles  from  drug-treated  cultures  were  non-infectious,  presumably 
because they lacked DNA cores. Our results indicate that a different situation 
exists  with  SV40.  In  the  electron microscope very few virus particles  were 
seen in thin sections of SV40-infected  cells tested with FU. Since considerable 
amounts of virus antigen can be located in the nuclei of the vast majority of 
cells by the fluorescent antibody technique, the absence of empty virus particles 322  SIMIAN  PAPOVAVIRUS  SV40 
is not due to lack of protein synthesis. The  ~  electron microscopic results suggest 
that the large amounts of SV40 antigen produced are not assembled into the 
protein capsid in the presence of fluorouracil. 
At least four laboratories have reported that SV40  induces the malignant 
transformation of cell cultures prepared from embryonic or newborn hamsters. 
In two laboratories (33, 34)  the transformation was associated with the con- 
tinuous appearance  of virus  in  the  cultures.  In  the  other  two laboratories 
(9, 35), infective virus could not be found in the transformed cultures. However, 
Shein et al.  (35) observed a faint circumnucleolar fluorescence in transformed 
cells stained with SV40 antibody by the indirect fluorescent antibody method, 
and suggested  that  this might result from the presence  of an  SV40-specific 
antigen not associated with infectious virus. Huebner et al. have recently found 
that cells  transformed by SV40  but free of the virus contain a  specific  viral 
complement-fixing antigen, similar to the findings in tumor cells resulting from 
adenovirus infection of hamsters  (8).  However no evidence was obtained to 
show that the viral CF antigen in the tumor was related to the viral antigen 
detected in the present study (36). 
There  is other evidence to show that a  specific  non-infectious antigen, in 
some way related to SV40, is present in the hamster tumor cells induced by this 
virus (37-40).  Adult hamsters immunized with live SV40 become resistant to 
SV40 tumor cells, even when virus-free transformed cells are used for challenge. 
Injection of the murine papovavirus  (polyoma)  confers no  such  immunity, 
although suggestive crossings against SV40 were obtained with papovaviruses 
of rabbit  and man  (40).  The present experiments indicate a  possible probe 
towards  the  production  of  such  non-infectious  viral  protein  antigens  even 
before they are assembled into viral capsids. 
SUMMARY 
A study was made  of the effects  of 5-fluorouracil  (FU)  and 5-fluoro- 
deoxyuridine (FUDR) on the replication  of the simian  papovavirus SV40 in 
cercopithecus  monkey kidney cells  and on the production of  virus  antigen  by 
these  cells.  Both drugs markedly suppressed  the production  of new infectious 
virus by SV40-infected  cells.  Synthesis  of viral  protein  was also  markedly 
suppressed  by FUDR, but not by FU. 
In the  presence  of  FU, infected  cells  produced large  amounts of  viral  protein 
which  were  detected  by  the  fluorescent  antibody  technique.  The antigen  was  not 
distributed in a particulate fashion as in untreated cells. Diffuse virus antigen 
was observed in the nuclei of FU-treated cells, resembling the distribution of 
antigen near the end of the eclipse period in untreated, infected cultures. This 
stage of antigen production presumably preceded viral assembly. 
Virus  particles  with  or  without cores  were  rarely seen  with  the  electron 
microscope  in  infected  FU-treated  cells,  although  large  numbers  of  SV40 JOSEPH L.  MELNICK, SARA E.  STINEBAUGH, AND ]FRED RAPP  323 
particles were readily visualized in untreated, infected cells.  I,t appears that at 
least one antigenic protein of this papovavirus is synthesized abundantly in 
FU-treated cells,  but is not assembled into virus shells in the presence of the 
inhibitor. 
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EXPLANATION OF PLATES 
P~  27 
FIGs.  1 to 6. Immunofluorescence photomicrographs of green monkey kidney cells 
40 hours following inoculation with SV40. Fluorouracil not present. 
FIG. 1.  Virus antigens localized in the nuclei of 75 to 90 per cent of the cells.  X  180. 
FIG. 2.  Particulate virus antigen in the nuclei.  Note dark, non-reactlng nucleoli. 
X  720. 
FIGs.  3 and  4.  Intranucleax particulate  virus antigen varying in  size and  shape. 
Note dark, non-reacting nudeoli.  X  1800. 
FIGs. 5 and 6. One cell shows particulate virus antigen concentrated at the nuclear 
membrane.  Some  show intranudear  virus  antigen  distributed  diffusely throughout 
the nucleus.  ×  1800. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  119  PLATE  27 
(Melnick et al.:  Simian papovavirus SV40) PLATE 28 
Fins. 7 to  11. Immunofluorescence photomicrographs of green monkey kidney cells 
40 hours following inoculation with  SV40 in the presence of fluorouracil at a concen- 
tration of 12 t~g/ml. 
FIG. 7.  Virus antigen localized in the nuclei of 75 to 90 per cent of the cells.  X  180. 
FIG. 8.  Intranuclear virus antigen distributed as diffuse  or finely granular material. 
×  720. 
FIG. 9.  Diffuse virus antigen; note dark, non-reacting nuclei.  ×  1800. 
FIG.  10.  Diffuse virus antigen  concentrated at nuclear membrane of cell in lower 
left.  X  1800. 
Fro. 11.  A rare cell with small particles of virus antigen.  X  1800. 
FIG. 12.  Immunofluorescence photomicrograph of uninfected green monkey kidney 
cells  exposed  to  FU for 40  hours; reacted with anti-SV40 fluorescein-labeled serum. 
X  180. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  119  PLATE  28 
(Melnick et al.:  Simian papovavirus SV40) PLATE 29 
FIGS. 13 to 18.  Photomicrographs of green monkey kidney cells stained with hema- 
toxylin and eosin. 
FIG. 13.  Normal cells in the absence of virus or drug. X 600. 
FIG. 14.  Uninfected cells treated with 12 #g FU/ml. X 6C0. 
FIGS. 15 and 16.  Cells inoculated 72 hours  previously with  SV40. No  FU. Note 
pyknotic nuclei, clumping of  chromatin, vacuolation, and destruction of  cell  shcet. 
Fig. 15,  X 6C0. Fig. 16,  ×  750. 
FIGS. 17 and 18.  FU-treated cells inoculated 72 hours previously with SV40. Small 
intranuclear bodies are evident in some cells. Cell sheet is intact. ×  6(~0. THE  JOURNAL  O]?  EXPERIMENTAL  MEDICINE  VOL. 119  PLATE  29 
(Melnick et al.:  Simian papovavirus SV40) PLATE 30 
FIG.  19.  Electron micrograph of green monkey kidney  cells 72 hours after inocula- 
tion with SV40. No FU. Numerous virus particles (VP) are seen in  the nucleus  (N) 
and  within  the  nucleolus  (Nc). Nuclear  chromatin  (C)  can  be  seen  just  inside  the 
nuclear membrane (NM). Particles have mean diameter of 42 m#.  X 42,000. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  119  PLATE 30 
(Melnick et al.:  Simian papovavirus SV40) PLATE 31 
FIGS. 20 and 21. Electron micrographs of two FU-treated cells 72 hours after inocu- 
lation with SV40.  Chromatin is distributed  throughout the nucleus  (N).  Some areas 
(A) may be seen in which particles ranging from 10 to 40 m/~ in size are clustered, per- 
haps in an abortive attempt at virus replication.  X 23,500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 119  PLATE  31 
(Melnick et a/.: Simian papovavirus SV40) 